Ian W Rodger

McMaster University - Hamilton / Canada

Others

AD Scientific Index ID: 645647

Registration, Add Profile,
Premium Membership

Print Your Certificate

Ian W Rodger's MOST POPULAR ARTICLES

1-) Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2 The Journal of pharmacology and experimental therapeutics 296 (2), 558-566, 2001

2-) The discovery of rofecoxib,[MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2 (5H)-furanone], an orally active cyclooxygenase-2 inhibitor Bioorganic & medicinal chemistry letters 9 (13), 1773-1778, 1999

3-) Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5 H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles The Journal of pharmacology and experimental therapeutics 290 (2), 551-560, 1999

4-) Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure Circulation 98 (2), 100-103, 1998

5-) Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor British journal of pharmacology 121 (1), 105-117, 1997

ARTICLES

Add your articles